Opportunity

DIBBS #SPE2DP-26-T-2935

DLA Solicitation for Atenolol Tablets, 25 mg, 100 Count – Overseas Military Delivery

Posted

April 17, 2026

Respond By

April 22, 2026

Identifier

SPE2DP-26-T-2935

NAICS

424210

This procurement opportunity from the Defense Logistics Agency (DLA) seeks FDA-regulated Atenolol Tablets, 25 mg, 100 count, for delivery to a U.S. military base overseas. - Government Buyer: - Defense Logistics Agency (DLA) - DLA Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - OEMs and Approved Vendors: - MCKESSON CORPORATION (part number 463649) - MYLAN PHARMACEUTICALS INC (part number NDC00378-0218-01) - TEVA PHARMACEUTICALS USA, INC. (part number NDC00093-0787-01) - Products Requested: - Atenolol Tablets, US, 25 mg, 100 count (NSN 6505-01-336-6196) - Quantity: 1 bottle - Notable Requirements: - Delivery required within 20 days to Prince Sultan Air Base, Saudi Arabia (FOB destination) - Packaging must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1 - Shelf life of 36 months, non-extendable - Compliance with Buy American Act, hazardous material labeling, and NIST SP 800-171 cybersecurity standards - Place of Performance/Delivery: - Prince Sultan Air Base, Saudi Arabia - DLA Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA (contracting office)

Description

ATENOLOL TABLETS, US (QTY: 1, NSN: 6505-01-336-6196, Purchase Request: 7016354588) Approved Sources: - CAGE: 34WR5, Part No: 463649, Company: MCKESSON CORPORATION - CAGE: 3KJG9, Part No: NDC00378-0218-01, Company: MYLAN PHARMACEUTICALS INC - CAGE: 3V8D7, Part No: NDC00093-0787-01, Company: TEVA PHARMACEUTICALS USA, INC.

View original listing